header logo image


Page 5«..4567..1020..»

Archive for the ‘Gene therapy’ Category

BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week – PR Newswire

Wednesday, January 17th, 2024

BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week  PR Newswire

See more here:
BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week - PR Newswire

Read More...

In shift, Texas to cover initial consult for Afghan baby’s gene therapy – STAT – STAT

Wednesday, January 17th, 2024

In shift, Texas to cover initial consult for Afghan baby's gene therapy - STAT  STAT

See the original post:
In shift, Texas to cover initial consult for Afghan baby's gene therapy - STAT - STAT

Read More...

Genevant Sciences forges $114M deal with Tome Biosciences on liver disease gene therapy – LabPulse

Wednesday, January 17th, 2024

Genevant Sciences forges $114M deal with Tome Biosciences on liver disease gene therapy  LabPulse

Here is the original post:
Genevant Sciences forges $114M deal with Tome Biosciences on liver disease gene therapy - LabPulse

Read More...

Precision Medicine’s Breakout Year: 2024 Trends – Pharmaceutical Executive

Wednesday, January 17th, 2024

Precision Medicine's Breakout Year: 2024 Trends  Pharmaceutical Executive

Originally posted here:
Precision Medicine's Breakout Year: 2024 Trends - Pharmaceutical Executive

Read More...

$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs – Genetic Literacy…

Wednesday, January 17th, 2024

$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs  Genetic Literacy Project

View original post here:
$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs - Genetic Literacy...

Read More...

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE Trial of ABBV-RGX-314 for the Treatment of … – PR Newswire

Wednesday, January 17th, 2024

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE Trial of ABBV-RGX-314 for the Treatment of ...  PR Newswire

Read the original post:
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE Trial of ABBV-RGX-314 for the Treatment of ... - PR Newswire

Read More...

Sarepta Rebounded. Its Gene Therapy Is Back on Course. – Barron’s

Wednesday, January 17th, 2024

Sarepta Rebounded. Its Gene Therapy Is Back on Course.  Barron's

Visit link:
Sarepta Rebounded. Its Gene Therapy Is Back on Course. - Barron's

Read More...

Adimmune to investigate HIV gene therapy without SOC in Phase Ib trial – Clinical Trials Arena

Wednesday, January 17th, 2024

Adimmune to investigate HIV gene therapy without SOC in Phase Ib trial  Clinical Trials Arena

Read the rest here:
Adimmune to investigate HIV gene therapy without SOC in Phase Ib trial - Clinical Trials Arena

Read More...

Gene therapy offers hope for 4-year-old Woodlands boy with Duchenne muscular dystrophy – Houston Chronicle

Wednesday, January 17th, 2024

Gene therapy offers hope for 4-year-old Woodlands boy with Duchenne muscular dystrophy  Houston Chronicle

Go here to read the rest:
Gene therapy offers hope for 4-year-old Woodlands boy with Duchenne muscular dystrophy - Houston Chronicle

Read More...

Pink Sheet Podcast: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI :: Pink Sheet – Pink Sheet

Wednesday, January 17th, 2024

Pink Sheet Podcast: Project Orbis For Gene Therapy, US FDA Leaders' 2024 Predictions, FDA and AI :: Pink Sheet  Pink Sheet

Original post:
Pink Sheet Podcast: Project Orbis For Gene Therapy, US FDA Leaders' 2024 Predictions, FDA and AI :: Pink Sheet - Pink Sheet

Read More...

Clearway Health Launches Innovative Model to Support Health Systems in Enabling Access to Breakthrough Gene … – PR Newswire

Wednesday, January 17th, 2024

Clearway Health Launches Innovative Model to Support Health Systems in Enabling Access to Breakthrough Gene ...  PR Newswire

Link:
Clearway Health Launches Innovative Model to Support Health Systems in Enabling Access to Breakthrough Gene ... - PR Newswire

Read More...

Sarepta Therapeutics Initiates Screening in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of … – Business Wire

Wednesday, January 17th, 2024

Sarepta Therapeutics Initiates Screening in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of ...  Business Wire

Continue reading here:
Sarepta Therapeutics Initiates Screening in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of ... - Business Wire

Read More...

Dallas hospital among those approved to provide new gene therapy for sickle cell disease – FOX 4 News Dallas-Fort Worth

Wednesday, January 17th, 2024

Dallas hospital among those approved to provide new gene therapy for sickle cell disease  FOX 4 News Dallas-Fort Worth

See the original post here:
Dallas hospital among those approved to provide new gene therapy for sickle cell disease - FOX 4 News Dallas-Fort Worth

Read More...

Virica Expands Bioprocessing Capabilities with Carleton University Partnership – Carleton Newsroom

Wednesday, January 17th, 2024

Virica Expands Bioprocessing Capabilities with Carleton University Partnership  Carleton Newsroom

Link:
Virica Expands Bioprocessing Capabilities with Carleton University Partnership - Carleton Newsroom

Read More...

Center for Inherited Blood Disorders Administers Country’s First Gene Therapy Infusion to Treat Hemophilia A – Business Wire

Wednesday, January 17th, 2024

Center for Inherited Blood Disorders Administers Country's First Gene Therapy Infusion to Treat Hemophilia A  Business Wire

Visit link:
Center for Inherited Blood Disorders Administers Country's First Gene Therapy Infusion to Treat Hemophilia A - Business Wire

Read More...

First patient dosed in trial of hemophilia A gene therapy BBM-H803 – Hemophilia News Today

Wednesday, January 17th, 2024

First patient dosed in trial of hemophilia A gene therapy BBM-H803  Hemophilia News Today

Read the rest here:
First patient dosed in trial of hemophilia A gene therapy BBM-H803 - Hemophilia News Today

Read More...

Arbor, 4DMT partner on new gene therapies in ALS, other diseases – ALS News Today

Wednesday, January 17th, 2024

Arbor, 4DMT partner on new gene therapies in ALS, other diseases  ALS News Today

The rest is here:
Arbor, 4DMT partner on new gene therapies in ALS, other diseases - ALS News Today

Read More...

Children’s Health To Offer New Gene Therapy – The Dallas Express

Wednesday, January 17th, 2024

Children's Health To Offer New Gene Therapy  The Dallas Express

See original here:
Children's Health To Offer New Gene Therapy - The Dallas Express

Read More...

Atsena Therapeutics Receives Rare Pediatric Disease Designation from FDA for ATSN-101 Gene Therapy for … – GlobeNewswire

Wednesday, January 17th, 2024

Atsena Therapeutics Receives Rare Pediatric Disease Designation from FDA for ATSN-101 Gene Therapy for ...  GlobeNewswire

Read more:
Atsena Therapeutics Receives Rare Pediatric Disease Designation from FDA for ATSN-101 Gene Therapy for ... - GlobeNewswire

Read More...

UPDATED: Bluebird’s sickle cell gene therapy comes with safety warning and higher price. Can Lyfgenia overcome … – FiercePharma

Wednesday, December 13th, 2023

UPDATED: Bluebird's sickle cell gene therapy comes with safety warning and higher price. Can Lyfgenia overcome ...  FiercePharma

Follow this link:
UPDATED: Bluebird's sickle cell gene therapy comes with safety warning and higher price. Can Lyfgenia overcome ... - FiercePharma

Read More...

Page 5«..4567..1020..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick